Position in OVID
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,955,436
+$8,029,275 QoQ
Shares Held
4,072,653
+209.0% QoQ
Ownership
2.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 130 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. OVID ranks #184 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in OVID
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,955,436 | 4,072,653 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,926,161 | 1,318,091 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,095,365 | 672,004 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $842,425 | 648,020 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $212,300 | 643,335 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $415,269 | 1,330,993 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,241,691 | 1,329,435 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,554,449 | 1,317,330 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,001,632 | 1,302,514 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,843,240 | 1,260,079 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,970,012 | 1,232,923 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,610,983 | 1,200,777 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,978,918 | 1,213,085 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,289,058 | 499,635 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $929,321 | 499,635 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $905,414 | 492,073 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,050,137 | 488,436 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,550,714 | 493,858 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,842,093 | 573,861 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,851,030 | 550,902 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,761,548 | 450,524 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,070,624 | 763,837 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,320,705 | 571,734 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,271,329 | 569,918 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,331,776 | 587,758 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $876,230 | 294,037 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||